Colleen A. Lawton
Medical College of Wisconsin
Radiation Oncology
Milwaukee
WI 53226
USA
Name/email consistency: high
- Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31. Lawton, C.A., Winter, K., Grignon, D., Pilepich, M.V. J. Clin. Oncol. (2005)
- Hormones and radiation therapy in locally advanced adenocarcinoma of the prostate. Lawton, C.A. Semin. Radiat. Oncol (2003)
- Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. Lawton, C.A., Winter, K., Murray, K., Machtay, M., Mesic, J.B., Hanks, G.E., Coughlin, C.T., Pilepich, M.V. Int. J. Radiat. Oncol. Biol. Phys. (2001)